Fig. 2From: Persistence to anti-CGRP monoclonal antibodies and onabotulinumtoxinA among patients with migraine: a retrospective cohort studyPatients identified to have a claim for an anti-CGRP mAb or onabotulinumtoxinA. Anti-CGRP mAb, anti-calcitonin gene-related peptide monoclonal antibodyBack to article page